What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
Constance A. Benson mainly focuses on Internal medicine, Immunology, Intensive care medicine, Acquired immunodeficiency syndrome and Randomized controlled trial.
Her work on Cohort is typically connected to Phage therapy as part of general Internal medicine study, connecting several disciplines of science.
Her Intensive care medicine research incorporates themes from Integrase inhibitor and Emtricitabine.
Her Emtricitabine study combines topics in areas such as Raltegravir, Tenofovir alafenamide and Reverse-transcriptase inhibitor.
Her Acquired immunodeficiency syndrome research integrates issues from Guideline, Disease and Tuberculosis.
Her Randomized controlled trial research is multidisciplinary, relying on both Congenital cytomegalovirus infection, Retinite, Rifabutin and Mycobacterium avium-intracellulare infection.
Her most cited work include:
- Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel (2345 citations)
- Effect of early versus deferred antiretroviral therapy for HIV on survival. (970 citations)
- Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. (887 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Immunology, Internal medicine, Acquired immunodeficiency syndrome, Virology and Randomized controlled trial.
Her Immunology research is multidisciplinary, incorporating perspectives in Immune reconstitution inflammatory syndrome and Disease.
Her study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Surgery and Viral load.
Her Acquired immunodeficiency syndrome study integrates concerns from other disciplines, such as Clinical trial, Incidence, Tuberculosis and Intensive care medicine.
In her research, Abacavir and Reverse-transcriptase inhibitor is intimately related to Emtricitabine, which falls under the overarching field of Intensive care medicine.
The concepts of her Virology study are interwoven with issues in Antibody and Ritonavir.
She most often published in these fields:
- Immunology (40.61%)
- Internal medicine (36.36%)
- Acquired immunodeficiency syndrome (30.91%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (36.36%)
- Medical education (4.24%)
- Dolutegravir (3.64%)
In recent papers she was focusing on the following fields of study:
Constance A. Benson mainly investigates Internal medicine, Medical education, Dolutegravir, Adverse effect and Acquired immunodeficiency syndrome.
Her Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Tuberculosis.
The various areas that Constance A. Benson examines in her Dolutegravir study include Treatment outcome, Lamivudine, Dual therapy and Viral shedding.
Her Lamivudine study necessitates a more in-depth grasp of Virology.
Constance A. Benson applies her multidisciplinary studies on Acquired immunodeficiency syndrome and Risk assessment in her research.
The Intensive care medicine study combines topics in areas such as Psychological intervention and Incidence.
Between 2017 and 2021, her most popular works were:
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel (310 citations)
- Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial (49 citations)
- Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel. (45 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
Her primary scientific interests are in Internal medicine, Randomized controlled trial, Clinical trial, Dolutegravir and Integrase inhibitor.
Her research in Internal medicine intersects with topics in Antibiotic resistance and Varicella zoster virus.
The study incorporates disciplines such as VIROLOGIC FAILURE, Maintenance therapy, Lamivudine, Pediatrics and Drug resistance in addition to Dolutegravir.
Her Integrase inhibitor research is multidisciplinary, incorporating elements of Coinfection, Regimen, Tenofovir alafenamide and Intensive care medicine.
Her Intensive care medicine study combines topics in areas such as Bictegravir, Emtricitabine, Disease and Abacavir.
Constance A. Benson has researched Polypharmacy in several fields, including Pharmacotherapy and Acquired immunodeficiency syndrome.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
